The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsHealth
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. Released May 30, 2017.
About This Episode
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval is an episode from FDA Drug Information Updates by ReachMD. The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common...
Podcast
This episode belongs to FDA Drug Information Updates.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 30, 2017, 00:06:00 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Information Updates.
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
May 4, 2018 - 00:02:59
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Jan 7, 2018 - 00:08:29
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
Jan 5, 2018 - 00:02:59
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Oct 29, 2017 - 00:09:22
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Aug 17, 2017 - 00:05:29
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Jul 28, 2017 - 00:06:00
Questions About This Episode
What is FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval about?
The D.I.S.C.O. hosts discuss the agency’s first approval of pembrolizumab, a cancer treatment based on a common biomarker rather than the location in the body where the tumor originated. Released May 30, 2017.
Where can I listen to FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval?
You can listen to FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval from?
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval is an episode from FDA Drug Information Updates by ReachMD.
How long is this episode?
This episode is 00:06:00 long.
When was this episode published?
This episode was published on May 30, 2017.
Can I save FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Information Updates?
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.